跳至主要内容
临床试验/NCT01668927
NCT01668927已完成4 期

Helicobacter Pylori Treatment

Shanghai Jiao Tong University School of Medicine1 个研究点 分布在 1 个国家目标入组 424 人开始时间: 2012年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
424
试验地点
1
主要终点
eradication rate of H. pylori

研究概览

简要总结

The increase of antibiotic resistance to H. pylori causes failure of treatment. Furazolidone, amoxicillin and tetracycline are good candidates for rescue therapy since resistance to these three antimicrobials was rare. It is necessary to assess the efficacy and safety of these four bismuth-containing quadruple regimens with above antibiotics as empirical rescue therapies for H. pylori eradication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • H. pylori -positive patients with functional dyspepsia and scarred peptic ulcers who had previously failed one or more eradication regimens containing clarithromycin, metronidazole and/or amoxicillin.

排除标准

  • less than 18 years old, never receiving eradication treatment before, with previous gastric surgery, pregnancy, lactation, major systemic diseases, administration of antibiotics, bismuth, antisecretory drugs in the preceding 8 weeks

研究组 & 干预措施

tetracycline/furazolidone

Experimental

one of the four empirical rescue therapies

干预措施: Bismuth (Drug)

tetracycline/furazolidone

Experimental

one of the four empirical rescue therapies

干预措施: Tetracycline (Drug)

tetracycline/furazolidone

Experimental

one of the four empirical rescue therapies

干预措施: Proton Pump Inhibitor (Drug)

tetracycline/furazolidone

Experimental

one of the four empirical rescue therapies

干预措施: Furazolidone (Drug)

amoxicillin/tetracycline

Experimental

one of the four empirical rescue therapies

干预措施: Proton Pump Inhibitor (Drug)

amoxicillin/tetracycline

Experimental

one of the four empirical rescue therapies

干预措施: Bismuth (Drug)

amoxicillin/tetracycline

Experimental

one of the four empirical rescue therapies

干预措施: Tetracycline (Drug)

amoxicillin/tetracycline

Experimental

one of the four empirical rescue therapies

干预措施: Amoxicillin (Drug)

amoxicillin/furazolidone

Experimental

one of the four empirical rescue therapies

干预措施: Proton Pump Inhibitor (Drug)

amoxicillin/furazolidone

Experimental

one of the four empirical rescue therapies

干预措施: Bismuth (Drug)

amoxicillin/furazolidone

Experimental

one of the four empirical rescue therapies

干预措施: Furazolidone (Drug)

amoxicillin/furazolidone

Experimental

one of the four empirical rescue therapies

干预措施: Amoxicillin (Drug)

tetracycline /metronidazole

Active Comparator

Classical rescue therapy

干预措施: Proton Pump Inhibitor (Drug)

tetracycline /metronidazole

Active Comparator

Classical rescue therapy

干预措施: Bismuth (Drug)

tetracycline /metronidazole

Active Comparator

Classical rescue therapy

干预措施: Metronidazole (Drug)

tetracycline /metronidazole

Active Comparator

Classical rescue therapy

干预措施: Tetracycline (Drug)

结局指标

主要结局

eradication rate of H. pylori

时间窗: 2 months

次要结局

未报告次要终点

研究者

发起方
Shanghai Jiao Tong University School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. HONG LU

professor of GI Division, Renji Hospital

Shanghai Jiao Tong University School of Medicine

研究点 (1)

Loading locations...

相似试验